DFTX Raises $805M
Definium Therapeutics, Inc. closes $805 million upsized public offering, including full exercise of underwriters' option to purchase additional shares
DFTX Definium Therapeutics, Inc.
Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares